arBtrage CAPITALIZING MARKETS checking… Sign in

Anavex Life Sciences Corp.

AVXL Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$2.57
▼ -8.9% Today
as of Jun 7, 07:09 ET
Last 30 days -23.74% Apr 28 → Jun 05
$2.50 $2.75 $2.99 $3.23 $3.48 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$2.82
High
$2.82
Low
$2.56
Volume
$941,535
Avg Vol
$2M
Mkt Cap
$261M
P/E (TTM)
Beta
52w High
$13.99
52w Low
$2.56
Div Yield
Shares Out
$93M

Overview

52-week range
$2.56
$14
0% of range
Avg surprise (last 1)
+18.8%
Avg reaction (last 1)
-5.0%
0% positive
Latest IV / EM
162%
EM ±22.4% · $3 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.17$-0.14$-0.12$-0.09$-0.06 Actual $-0.17Actual $-0.14Actual $-0.11Actual $-0.13Actual $-0.14Actual $-0.14Actual $-0.13Est $-0.16Actual $-0.16Actual $-0.06 MarJunDecMarJunDecMar/2025JunDec
Revenue vs Net Income Revenue Net income
$-13M$-11M$-10M$-8M$-6M Mar 24Jun 24Dec 24Mar 25Jun 25Dec 25

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed Dec 31, 2025Dec 2025 $-0.06 financials
Mon Jun 30, 2025Jun 2025 $-0.16 financials
Tue May 13, 2025Mar/2025 $-0.13 $-0.16 +18.8% -5.0% earnings
Tue Dec 31, 2024Dec 2024 $-0.14 financials
Sun Jun 30, 2024Jun 2024 $-0.14 financials
Sun Mar 31, 2024Mar 2024 $-0.13 financials
Sun Dec 31, 2023Dec 2023 $-0.11 financials
Fri Jun 30, 2023Jun 2023 $-0.14 financials
Fri Mar 31, 2023Mar 2023 $-0.17 financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Tue Jun 9, 2026Mar/2026OTHER -$0.07-$0.13 +46.1%

Financials

Income statement (quarterly)

MetricDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
Revenue
Cost of revenue
Gross profit
Operating income$-7M$-14M$-13M$-14M$-15M$-13M
Net income$-6M$-13M$-11M$-12M$-12M$-11M
EPS (diluted)$-0.06$-0.16$-0.13$-0.14$-0.14$-0.13

Balance sheet (quarterly)

MetricDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
Cash & equivalents$132M$103M$101M$116M$121M$132M$139M$139M
Inventory
Total current assets
Total assets$133M$104M$102M$117M$124M$136M$142M$145M
Long-term debt
Total liabilities$6M$9M$11M$17M$13M$15M$12M$10M
Total equity$127M$95M$91M$100M$111M$120M$130M$135M

Implied volatility — last 90 days

161%173%185%196%208% Jun 06 — IV 208% · EM ±38.0%Jun 07 — IV 162% · EM ±22.4%

Sector peers